Price $201.80 |
Market Cap
35.03B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
13.6
|
P/B
2.5
|
P/S
3.62
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
31.6
|
Op. Cash Flow
1.43M
|
FCF
7.9
|
|
Op. Margin
31.20%
|
Net Margin
26.70%
|
ROE
19.60%
|
ROI
17.50%
|
|
ROA
10.70%
|
EPS Growth
31.40%
|
Current Ratio
3.0
|
Debt/Equity
46.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CYANOTECH CORP (CYAN) | $0.72 | - | - | 4.4M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $11.55 | - | - | 78M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
